2 3 4 Next Last 
jameshebrew's Updates (48)

  • jameshebrew
  • The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10% Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party service providers that offer customized services and advanced technologies. Roots Analysis has announced the addition of “Companion Diagnostics Development Services Market (2nd Edition), 2022-2035” report to its list of... [more]
  • jameshebrew
  • The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% till 2035, claims Roots Analysis Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initiatives to become one-stop-shops to cater to the diverse needs of ADC developers. London Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (5th Edition),... [more]
  • jameshebrew
  • PRESENTLY, MORE THAN 100 PLAYERS ACROSS THE GLOBE CLAIM TO OFFER NUTRIGENOMICS TESTS / SERVICES BASED ON GENETIC ASSESSMENT Given the recent shift from the one-size-fits-all model to a more personalized mode of treatment, there has been a growing interest in identification and adoption of novel techniques. It is estimated that there are around 20,000 genes present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Since the... [more]
  • jameshebrew
  • RNAI THERAPY OFFERS THE POTENTIAL TO REVOLUTIONIZE THE BIOPHARMACEUTICAL INDUSTRY Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several big pharma players have undertaken RNAi focused initiatives. In addition to effective gene silencing, these candidates can be deployed for applications related to precision medicine. Studies have also demonstrated the safety of RNAi therapeutics for in... [more]
  • jameshebrew
  • The taste masking market is anticipated to grow at a steady pace till 2035, claims Roots Analysis Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years. London Roots Analysis has announced the addition of “Taste masking and Taste Assessment Services and Technologies Market,... [more]
  • jameshebrew
  • The DNA and gene cloning services market is anticipated to grow at a CAGR of over 15% by 2035, claims Roots Analysis In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players have demonstrated a preference to leverage expertise of DNA and gene cloning service providers. London Roots Analysis has announced the addition of “DNA and Gene Cloning Market , 2022-2035” report to its... [more]
  • jameshebrew
  • The mini bioreactors and microbioreactors market is anticipated to grow at an annualized rate of 8% till 2035, claims Roots Analysis Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations and applications ranging from media development to process optimization Roots Analysis has announced the addition of “Mini Bioreactors and Micro Bioreactors Market, 2022-2035” report... [more]
  • jameshebrew
  • The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent malignancies. London Roots Analysis has announced the addition of “Artificial Intelligence in Oncology Market,... [more]
  • jameshebrew
  • The precision medicine software developers market is projected to grow at an annualized rate of 30%, till 2032, claims Roots Analysis Given their ability to cater to the existing unmet needs in the healthcare sector, various industry stakeholders have made investments for the development and implementation of precision medicine software applications for diagnosis, analysis and treatment of a range of disorders. Roots Analysis has announced the addition of “Precision Medicine... [more]
  • jameshebrew
  • MEDICAL DEVICE DEVELOPERS HAVE BEEN COMPELLED TO OUTSOURCE THEIR MANUFACTURING OPERATIONS TO CONTRACT SERVICE PROVIDERS The in-house development of peptide API requires necessary expertise and capabilities, including design, construction and maintenance of a facility which demands significant capital investments. Therefore, several small drug developers and, at times, certain pharma giants as well, have started outsourcing their manufacturing operations to contract service providers.... [more]
  • jameshebrew
  • Steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers The current landscape of biologics fill / finish contract service providers features the presence of several established and emerging players, with a diverse set of production capabilities. The fill / finish services market is presently dominated by service providers (more than 95) based in North America and Europe. It is worth highlighting that some of... [more]
  • jameshebrew
  • MANUFACTURING EXECUTION SYSTEM PROVIDERS IN HEALTHCARE MARKET Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at a compound annual growth rate of 36%. It is important to consider that the constant management of such enormous volumes of data is a quite tedious process and... [more]
  • jameshebrew
  • INDUSTRY STAKEHOLDERS HAVE MADE SIGNIFICANT INVESTMENTS TOWARDS THE DEVELOPMENT OF ORALLY ADMINISTERED PROTEIN AND PEPTIDE THERAPEUTICS Over the years, advances in recombinant DNA technology and ex vivo synthesis of biomolecules have led to the development and (in some cases) approval of several protein / peptide-based therapeutics. Considering the therapeutic advantages associated with proteins and peptides, this field has witnessed significant activity; researchers are actively... [more]
  • jameshebrew
  • The human microbiome market is anticipated to grow at a CAGR of 24% till 2035, claims Roots Analysis With the increasing concept of precision medicine, several scientists have demonstrated interest in the therapeutic manipulation of human microbiome (commonly gut bacteria) for the treatment of a wide range of disease indications. Roots Analysis has announced the addition of “The Human Microbiome Market, (4th Edition) 2022-2035” report to its list of offerings. The... [more]
  • jameshebrew
  • The novel cardiovascular drug delivery devices market is projected to grow at a CAGR of 9.3%, till 2035, claims Roots Analysis Given the growing number of patients suffering from cardiovascular disorders and the high associated financial burden, cardiovascular drug eluting stents have emerged as a safe and efficient novel drug delivery device to assist in providing effectual treatment. Roots Analysis has announced the addition of “Novel Cardiovascular Drug Delivery Devices Market,... [more]
2 3 4 Next Last 

member since: May 16, 2022

0 following